The UK’s medicines regulator has approved a second monoclonal antibody, sotrovimab, for the treatment of people over 12 […]
World Health Organization states agreed on 1 December to begin negotiating an international agreement on how countries must […]
In their focus on equity in the post-covid NHS, Patel and colleagues emphasise “clinical prioritisation.”1 This idea is […]
China brought the first outbreak of covid-19 under control in March 2020. The response to the virus then […]
Scientific understanding about the epidemiology, genetics, and continuing evolution of covid-19 has been transformed since the disease was […]
Amgen’s Otezla notches win in genital psoriasis, snagging possible edge against forthcoming BMS rival fkansteiner Thu, 12/02/2021 – […]
Aspen Pharmacare, pursuing J&J vaccine license, aims to shore up local capacity and quash shot inequality in Africa […]
Fujifilm socks $530M into U.K. vaccine, gene therapy and microbial production, creating 350 jobs fkansteiner Wed, 12/01/2021 – […]
An advisory panel of experts has voted by 13 to 10 to recommend that the US Food and […]
General practice will require extra staff and capacity to offer covid-19 booster vaccines to everyone over the age […]